Literature DB >> 17258308

Suppressor of cytokine signaling in allergic inflammation.

Judit Knisz1, Paul B Rothman.   

Abstract

The immunopathological hallmark of allergic diseases is elevated total and allergen specific serum IgE levels along with inflammation. This inflammation results from the activation of a cadre of hematopoietic and nonhematopoetic cells. This coordinated activation is the result of the increased production of a variety of soluble factors including chemokines and cytokines. The magnitude and the duration of cytokine action will determine the response to an allergen, either mounting a low-grade immunologic response or resulting in exaggerated reaction such as asthma or atopic dermatitis. Thus, the action of cytokines is tightly regulated both developmentally and within the cell. The suppressor of cytokine signaling (SOCS) protein family represents a novel group of cytoplasmic negative feedback regulators of type I and II cytokines. Several of the signaling pathways regulated by SOCS proteins are important in allergic immune responses. Thus, SOCS proteins may be important regulators of atopy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17258308     DOI: 10.1016/j.jaci.2006.12.620

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Genetic correlation of SOCS3 polymorphisms with infantile asthma: an evidence based on a case-control study.

Authors:  Ying Fang; Xiaoxia Ren; Zhanwei Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Different regulation of T helper 1- and T helper 2-promoting cytokine signalling factors in human dendritic cells after exposure to protein versus contact allergens.

Authors:  Ingo Böttcher; Iris Bellinghausen; Bettina König; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

3.  Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses.

Authors:  Jennifer Zurney; Kristina E Howard; Barbara Sherry
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

4.  Gene expression profiling in lungs of chronic asthmatic mice treated with galectin-3: downregulation of inflammatory and regulatory genes.

Authors:  Esther López; M Paz Zafra; Beatriz Sastre; Cristina Gámez; Carlos Lahoz; Victoria del Pozo
Journal:  Mediators Inflamm       Date:  2011-03-20       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.